Belzutifan Efficacy in Von Hippel-Lindau Disease-Associated Renal Cell Carcinoma Versus Natural History Control Arm

Journal:
Journal of the National Cancer Institute
Published:
DOI:
10.1093/jnci/djag064
Affiliations:
3
Authors:
9
Go to article
Institutions Authors Share
Merck & Co, United States of America (USA)
6.000000
 0.67
NIH National Cancer Institute (NCI), United States of America (USA)
3.000000
 0.33
Interested in Oncology and Carcinogenesis?